Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease
Publication Date: October 1, 2018
Last Updated: March 14, 2022
Detection and evaluation of HCV in CKD
Screening patients with chronic kidney disease (CKD) for hepatitis C virus (HCV) infection
We recommend screening all patients for HCV infection at the time of initial evaluation of CKD. (Level 1, C)
312054
We recommend using an immunoassay followed by nucleic acid testing (NAT) if immunoassay is positive. (Level 1, A)
312054
We recommend screening all patients for HCV infection upon initiation of in-center hemodialysis or upon transfer from another dialysis facility or modality. (Level 1, A)
312054
We recommend using NAT alone or an immunoassay followed by NAT if immunoassay is positive. (Level 1, A)
312054
We suggest screening all patients for HCV infection upon initiation of peritoneal dialysis or home hemodialysis. (Level 2, D)
312054
We recommend screening all patients for HCV infection at the time of evaluation for kidney transplantation. (Level 1, A)
312054
Title
Hepatitis C in Chronic Kidney Disease
Authoring Organizations
Kidney Disease Improving Global Outcomes
National Kidney Foundation